Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Acetyl-L-carnitine in hepatic encephalopathy.

Malaguarnera M.

Metab Brain Dis. 2013 Jun;28(2):193-9. doi: 10.1007/s11011-013-9376-4. Review.

PMID:
23389620
2.

Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study.

Malaguarnera M, Vacante M, Giordano M, Pennisi G, Bella R, Rampello L, Malaguarnera M, Li Volti G, Galvano F.

Am J Clin Nutr. 2011 Apr;93(4):799-808. doi: 10.3945/ajcn.110.007393.

3.

Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.

Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Motta M, Mistretta A, Rampello L, Pennisi G.

Scand J Gastroenterol. 2011 Jun;46(6):750-9. doi: 10.3109/00365521.2011.565067.

PMID:
21443422
4.

Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.

Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, Cammalleri L, Pennisi G, Rampello L.

Dig Dis Sci. 2008 Nov;53(11):3018-25. doi: 10.1007/s10620-008-0238-6.

PMID:
18357530
5.

Oral acetyl-L-carnitine treatment in hepatic encephalopathy: view of evidence-based medicine.

Jiang Q, Jiang G, Shi KQ, Cai H, Wang YX, Zheng MH.

Ann Hepatol. 2013 Sep-Oct;12(5):803-9. Review.

6.

Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.

Blanco Vela CI, Poo Ramírez JL.

Ann Hepatol. 2011 Jun;10 Suppl 2:S55-9.

PMID:
22228883
7.

L-Carnitine in the treatment of mild or moderate hepatic encephalopathy.

Malaguarnera M, Pistone G, Astuto M, Dell'Arte S, Finocchiaro G, Lo Giudice E, Pennisi G.

Dig Dis. 2003;21(3):271-5.

PMID:
14571103
8.

Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.

Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G.

Metab Brain Dis. 2011 Dec;26(4):281-9. doi: 10.1007/s11011-011-9260-z.

PMID:
21870121
9.

Acetyl-L-carnitine for dementia.

Hudson S, Tabet N.

Cochrane Database Syst Rev. 2003;(2):CD003158. Review.

PMID:
12804452
10.

Ammonia-mediated LTP inhibition: effects of NMDA receptor antagonists and L-carnitine.

Izumi Y, Izumi M, Matsukawa M, Funatsu M, Zorumski CF.

Neurobiol Dis. 2005 Nov;20(2):615-24.

PMID:
15935684
11.

Minimal hepatic encephalopathy.

Dhiman RK, Chawla YK.

Indian J Gastroenterol. 2009 Jan-Feb;28(1):5-16. doi: 10.1007/s12664-009-0003-6. Review.

PMID:
19529896
12.

L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy.

Jalan R, Wright G, Davies NA, Hodges SJ.

Med Hypotheses. 2007;69(5):1064-9.

PMID:
17467190
13.

The molecular pathogenesis of hepatic encephalopathy.

Jalan R, Shawcross D, Davies N.

Int J Biochem Cell Biol. 2003 Aug;35(8):1175-81. Review.

PMID:
12757755
14.

Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat.

Therrien G, Rose C, Butterworth J, Butterworth RF.

Hepatology. 1997 Mar;25(3):551-6.

PMID:
9049197
15.

[Effects of L-acetylcarnitine on mental deterioration in the aged: initial results].

Cipolli C, Chiari G.

Clin Ter. 1990 Mar 31;132(6 Suppl):479-510. Italian.

PMID:
2140973
16.

Role of ammonia and inflammation in minimal hepatic encephalopathy.

Shawcross DL, Wright G, Olde Damink SW, Jalan R.

Metab Brain Dis. 2007 Mar;22(1):125-38.

PMID:
17260161
17.

Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.

Poo JL, Góngora J, Sánchez-Avila F, Aguilar-Castillo S, García-Ramos G, Fernández-Zertuche M, Rodríguez-Fragoso L, Uribe M.

Ann Hepatol. 2006 Oct-Dec;5(4):281-8.

PMID:
17151582
18.

Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.

Malaguarnera M, Risino C, Cammalleri L, Malaguarnera L, Astuto M, Vecchio I, Rampello L.

Eur J Gastroenterol Hepatol. 2009 Jul;21(7):762-70. doi: 10.1097/MEG.0b013e328309c791.

PMID:
19357525
19.

Acetyl-L-carnitine. Monograph.

[No authors listed]

Altern Med Rev. 2010 Apr;15(1):76-83. Review. No abstract available.

20.

Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy.

Siciliano M, Annicchiarico BE, Lucchese F, Bombardieri G.

Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):76-80.

PMID:
16445703
Items per page

Supplemental Content

Support Center